METHODS OF TREATMENT WITH MYOSIN MODULATOR

Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 13. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

CARLSON TIMOTHY [VerfasserIn]
DEL RIO CARLOS L [VerfasserIn]
EDELBERG JAY M [VerfasserIn]
FERNANDES SARAH [VerfasserIn]
HENZE MARCUS PATRICK [VerfasserIn]
MA GRACE YANFEI [VerfasserIn]
MCDOWELL ROBERT [VerfasserIn]
MEALIFFE MATTHEW EDWARDS [VerfasserIn]
SEHNERT AMY [VerfasserIn]
SEMIGRAN MARC J [VerfasserIn]
LAMPL KATHY L [VerfasserIn]
ZHANG DAVID [VerfasserIn]
DESAI MILIND Y [VerfasserIn]
NISSEN STEVE [VerfasserIn]
FANG LIANG [VerfasserIn]
LAMBING JOSEPH [VerfasserIn]
LI WANYING [VerfasserIn]
AUBELE DANIELLE L [VerfasserIn]
KANE BRIAN EDMUND [VerfasserIn]
SEHL LOUIS CHARLES [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-13, Last update posted on www.tib.eu: 2023-12-26, Last updated: 2023-12-29

Patentnummer:

EP4054588

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA015355845